BackLakeShore Biopharma Co Overview

LakeShore Biopharma Co Operating Income

Latest operating income for YS: $-450M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-181145517.00

As of Mar 31, 2024

Annual Operating Income (TTM)

$-446070517.00

Trailing 12 months ending Mar 31, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

LakeShore Biopharma Co (YS) FAQ

LakeShore Biopharma Co's operating income stands at $-450M as of March 2024. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Open the history chart to see whether LakeShore Biopharma Co's operating income is expanding or contracting. Sustained growth in operating income can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how LakeShore Biopharma Co's operating income evolved across reporting periods, while the comparison chart places YS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.